Serveur d'exploration COVID et hydrochloroquine - Exploration (Accueil)

Index « AbsEn.i » - entrée « increasing »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
increases < increasing < increasingly  Facettes :

List of bibliographic references indexed by increasing

Number of relevant bibliographic references: 56.
[0-20] [0 - 20][0 - 50][20-40]
Ident.Authors (with country if any)Title
000127 (2021) Thirumal Kumar D [Inde] ; Nishaat Shaikh [Inde] ; Udhaya Kumar S [Inde] ; George Priya Doss C [Inde] ; Hatem Zayed [Qatar]Structure-Based Virtual Screening to Identify Novel Potential Compound as an Alternative to Remdesivir to Overcome the RdRp Protein Mutations in SARS-CoV-2.
000183 (2021) Byung Jin Choi [Corée du Sud] ; Yeryung Koo [Corée du Sud] ; Tae Young Kim [Corée du Sud] ; Wou Young Chung [Corée du Sud] ; Yun Jung Jung [Corée du Sud] ; Ji Eun Park [Corée du Sud] ; Hong-Seok Lim [Corée du Sud] ; Bumhee Park [Corée du Sud] ; Dukyong Yoon [Corée du Sud]Risk of QT prolongation through drug interactions between hydroxychloroquine and concomitant drugs prescribed in real world practice.
000220 (2021) Mengmeng Zhao [République populaire de Chine] ; Jishou Zhang [République populaire de Chine] ; Hanli Li [République populaire de Chine] ; Zhen Luo [République populaire de Chine] ; Jing Ye [République populaire de Chine] ; Yao Xu [République populaire de Chine] ; Zhen Wang [République populaire de Chine] ; Di Ye [République populaire de Chine] ; Jianfang Liu [République populaire de Chine] ; Dan Li [République populaire de Chine] ; Menglong Wang [République populaire de Chine] ; Jun Wan [République populaire de Chine]Recent progress of antiviral therapy for coronavirus disease 2019.
000441 (2021) Asokan Devarajan [États-Unis] ; Marmar Vaseghi [États-Unis]Hydroxychloroquine can potentially interfere with immune function in COVID-19 patients: Mechanisms and insights.
000473 (2021) Jihad G. Youssef [États-Unis] ; Faisal Zahiruddin [États-Unis] ; George Youssef [États-Unis] ; Sriram Padmanabhan [États-Unis] ; Joe Ensor [États-Unis] ; Sai Ravi Pingali [États-Unis] ; Youli Zu [États-Unis] ; Sandeep Sahay [États-Unis] ; Swaminathan P. Iyer [États-Unis]G6PD deficiency and severity of COVID19 pneumonia and acute respiratory distress syndrome: tip of the iceberg?
000532 (2021) Shadma Wahab ; Md Faruque Ahmad ; Arshad Hussain ; Shazia Usmani ; Ambreen Shoaib ; Wasim AhmadEffectiveness of Azithromycin as add-on Therapy in COVID-19 Management.
000557 (2021) Nitesh Sanghai [Canada] ; Kashfia Shafiq [Canada] ; Geoffrey K. Tranmer [Canada]Drug Discovery by Drug Repurposing: Combating COVID-19 in the 21st Century.
000564 (2021) Mario Cazzola [Italie] ; Vito De Novellis [Italie] ; Andrea Bianco [Italie] ; Paola Rogliani [Italie] ; Maria Gabriella Matera [Italie]Disputes over the production and dissemination of misinformation in the time of COVID-19.
000585 (2021) Ruby Gupta [États-Unis] ; Sukhmani Singh [États-Unis] ; Nwabundo Anusim [États-Unis] ; Sachin Gupta [États-Unis] ; Sorab Gupta [États-Unis] ; Marianne Huben [États-Unis] ; George Howard [États-Unis] ; Ishmael Jaiyesimi [États-Unis]Coronavirus Disease 2019 and Cold Agglutinin Syndrome: An Interesting Case.
000637 (2021) Jun-Ichi Okada [Japon] ; Takashi Yoshinaga [Japon] ; Takumi Washio [Japon] ; Kohei Sawada [Japon] ; Seiryo Sugiura [Japon] ; Toshiaki Hisada [Japon]Chloroquine and hydroxychloroquine provoke arrhythmias at concentrations higher than those clinically used to treat COVID-19: A simulation study.
000695 (2021) Robin K. Avery [États-Unis]COVID-19 Therapeutics for Solid Organ Transplant Recipients; 6 Months Into the Pandemic: Where Are We Now?
000744 (2021) Omkar Indari [Inde] ; Shweta Jakhmola [Inde] ; Elangovan Manivannan [Inde] ; Hem Chandra Jha [Inde]An Update on Antiviral Therapy Against SARS-CoV-2: How Far Have We Come?
000758 (2021) Lorenzo A. Cal [Italie] ; Matteo Rigato [Italie] ; Luca Sgarabotto [Italie] ; Lisa Gianesello [Italie] ; Giovanni Bertoldi [Italie] ; Verdiana Ravarotto [Italie] ; Paul A. Davis [États-Unis]ACE2 and SARS-CoV-2 Infection Risk: Insights From Patients With Two Rare Genetic Tubulopathies, Gitelman's and Bartter's Syndromes.
000772 (2021) Juhi Saraswat [Inde] ; Prashant Singh [Inde] ; Rajan Patel [Inde]A computational approach for the screening of potential antiviral compounds against SARS-CoV-2 protease: Ionic liquid vs herbal and natural compounds.
000784 (2021) Francis Atemnkeng [États-Unis] ; Harith Alataby [États-Unis] ; Jack Demirjian [États-Unis] ; Foma Munoh Kenne [États-Unis] ; Jay Nfonoyim [États-Unis]A Novel Report on the Compassionate Use of Baricitinib in Treating a Pediatric Patient With Severe Symptoms of COVID-19 Infection.
000961 (2020) Mohammad Obeidat [États-Unis] ; Alexandra L. Isaacson [États-Unis] ; Stephanie J. Chen [États-Unis] ; Marina Ivanovic [États-Unis] ; Danniele Holanda [États-Unis]Zebra-like bodies in COVID-19: is phospholipidosis evidence of hydroxychloroquine induced acute kidney injury?
000A16 (2020) Jianjun Gao [République populaire de Chine] ; Shasha Hu [République populaire de Chine]Update on use of chloroquine/hydroxychloroquine to treat coronavirus disease 2019 (COVID-19).
000A46 (2020) Faryal Farooqi [États-Unis] ; Naveen Dhawan ; Richard Morgan [États-Unis] ; John Dinh [États-Unis] ; Kester Nedd [États-Unis] ; George Yatzkan [États-Unis]Treatment of Severe COVID-19 with Tocilizumab Mitigates Cytokine Storm and Averts Mechanical Ventilation During Acute Respiratory Distress: A Case Report and Literature Review.
000B20 (2020) Frédéric Carrière [France] ; Sonia Longhi [France] ; Michel Record [France]The endosomal lipid bis(monoacylglycero) phosphate as a potential key player in the mechanism of action of chloroquine against SARS-COV-2 and other enveloped viruses hijacking the endocytic pathway.
000B64 (2020) Serena Colafrancesco [Italie] ; Rossana Scrivo [Italie] ; Cristiana Barbati [Italie] ; Fabrizio Conti [Italie] ; Roberta Priori [Italie]Targeting the Immune System for Pulmonary Inflammation and Cardiovascular Complications in COVID-19 Patients.
000C21 (2020) Andreas Kronbichler [Autriche] ; Maria Effenberger [Autriche] ; Michael Eisenhut [Royaume-Uni] ; Keum Hwa Lee [Corée du Sud] ; Jae Il Shin [Corée du Sud]Seven recommendations to rescue the patients and reduce the mortality from COVID-19 infection: An immunological point of view.

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/CovidChloroV1/Data/Main/Exploration
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/AbsEn.i -k "increasing" 
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/AbsEn.i  \
                -Sk "increasing" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    CovidChloroV1
   |flux=    Main
   |étape=   Exploration
   |type=    indexItem
   |index=    AbsEn.i
   |clé=    increasing
}}

Wicri

This area was generated with Dilib version V0.6.38.
Data generation: Sat May 22 17:02:32 2021. Site generation: Sat May 22 17:06:52 2021